European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5 , Pages 491-493 , November 2006

Secondary Prevention of Arteriosclerosis in Lower Limb Vascular Amputees: A Missed Opportunity

  • L. Bradley
  • ,
  • S.G.B. Kirker

      Affiliations

    • Corresponding Author InformationCorresponding author. Dr. S.G.B. Kirker, MD, FRCPI, Addenbrooke's Hospital, Disablement Services Centre, Cambridge CB2 2QQ, UK.

,Accepted 13 July 2006.

References 

  1. National Amputee Statistical Database Steering Group. The Amputee Statistical Database for the United Kingdom. 2004.
  2. Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47(10):1255–1256
  3. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2(3):221–226
  4. Roth EJ, Park KL, Sullivan WJ. Cardiovascular disease in patients with dysvascular amputation. Arch Phys Med Rehabil. 1998;79(2):205–215
  5. McWhinnie DL, Gordon AC, Collin J, Gray DW, Morrison JD. Rehabilitation outcome 5 years after 100 lower-limb amputations. Br J Surg. 1994;81(11):1596–1599
  6. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265(9):1145–1151
  7. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348(9038):1339–1342
  8. Dey S, Mukherjee D. Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases. Curr Vasc Pharmacol. 2003;1(3):329–333
  9. McDermott MM, Guralnik JM, Greenland P, Pearce WH, Criqui MH, Liu K, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003;107(5):757–761
  10. Schillinger M, Exner M, Mlekusch W, Amighi J, Sabeti S, Muellner M, et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004;25(9):742–748
  11. Durazzo AE, Machado FS, Ikeoka DT, De BC, Monachini MC, Puech-Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967–975
  12. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg. 2004;39(2):357–365
  13. Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39(6):1178–1185
  14. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg. 2001;88(6):787–800
  15. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(2):161–172
  16. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329–1339
  17. Collaborative overview of randomised trials of antiplatelet therapy–II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ. 1994;308(6922):159–168
  18. Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Simioni P, et al. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg. 2000;19(4):370–380
  19. McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med. 2002;17(12):895–904
  20. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ. 2004;171(10):1189–1192
  21. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934
  22. Siriwardena GJ, Bertrand PV. Factors influencing rehabilitation of arteriosclerotic lower limb amputees. J Rehabil Res Dev. 1991;28(3):35–44
  23. Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003;108(12):1481–1486
  24. Youssef F, Seifalian AM, Jagroop IA, Myint F, Baker D, Mikhailidis DP, et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg. 2002;23(4):358–364
  25. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107(14):1848–1851
  26. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366(9500):1849–1861
  27. British Society of Rehabilitation Medicine. Amputee Rehabilitation: Recommended Standards & Guidelines. 2003.

PII: S1078-5884(06)00387-X

doi: 10.1016/j.ejvs.2006.07.005

European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5 , Pages 491-493 , November 2006